Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. May 21, 2022; 28(19): 2123-2136
Published online May 21, 2022. doi: 10.3748/wjg.v28.i19.2123
Table 1 Characteristics of non-severe acute pancreatitis and severe acute pancreatitis patients in derivation and validation cohort
CharacteristicDerivation cohort
P valueValidation cohort
P value
non-SAP (n = 327)
SAP (n = 80)
non-SAP (n = 131)
SAP (n = 59)
Age (yr)49.0 (36.0; 63.5)46.0 (34.8; 62.2)0.42440.0 (32.0; 58.5)44.0 (38.0; 53.0)0.371
Female (%)131 (40.1) 27 (33.8) 0.36363 (48.1) 14 (23.7) 0.003
Weekend admission (%)65 (19.9) 26 (32.5) 0.02337 (28.2) 13 (22.0) 0.471
Etiology (%)0.0210.003
Biliary113 (34.6) 31 (38.8) 54 (41.2) 11 (18.6)
Hypertriglyceridemia113 (34.6) 36 (45.0) 44 (33.6) 21 (35.6)
Alcoholic27 (8.26) 7 (8.75) 5 (3.82) 8 (13.6)
Others74 (22.6) 6 (7.50) 28 (21.4) 19 (32.2)
Peritoneal irritation (%)74 (22.6) 31 (38.8) 0.00527 (20.6) 32 (54.2) < 0.001
GCS < 15 (%)2 (0.61) 5 (6.25) 0.0043 (2.29) 7 (11.9) 0.011
Tem (℃)36.6 (36.4; 37.0)37.2 (36.5; 38.2)< 0.00137.0 (36.8; 37.4)38.0 (37.5; 38.4)< 0.001
SBP (KPa)17.2 (15.9; 18.7) 16.4 (14.9; 18.8) 0.11916.3 (15.2; 18.4) 16.8 (14.7; 19.5) 0.949
HR (bpm)82.0 (76.0; 94.5)118 (99.5; 132) < 0.00189.0 (79.0; 102) 110 (100; 130) < 0.001
RR (bpm)20.0 (18.0; 20.0)22.0 (20.0; 28.2)< 0.00120.0 (18.0; 21.0)23.0 (20.5; 29.5)< 0.001
WBC (× 109/L)11.6 (8.74; 15.2)14.2 (10.2; 18.7)0.00112.4 (8.70; 15.6)16.4 (12.2; 21.1)< 0.001
HCT (%)40.8 (37.5; 44.8)43.6 (36.9; 48.4)0.02241.3 (37.8; 45.0)42.9 (36.5; 49.0)0.218
PLT (×109/L)221 (178; 276) 192 (156; 274) 0.03232 (196; 278) 202 (166; 264) 0.025
K (mmol/L)3.90 (3.60; 4.25)3.90 (3.50; 4.30)0.8173.90 (3.50; 4.10)4.00 (3.50; 4.55)0.074
Na (mmol/L)137 (134; 140) 137 (132; 140) 0.909137 (133; 140) 137 (133; 140) 0.664
Ca (mmol/L)2.26 (2.13; 2.34)1.96 (1.74; 2.16)< 0.0012.22 (2.08; 2.32)1.93 (1.77; 2.10)< 0.001
Cr (μmol/L)67.0 (55.0; 80.0)90.0 (70.8; 142) < 0.00161.0 (52.0; 77.0)90.0 (62.5; 227) < 0.001
BUN (mmol/L)5.00 (3.88; 6.34)7.06 (5.26; 10.4)< 0.0014.66 (3.32; 5.84)6.67 (4.91; 14.2)< 0.001
Glu (mmol/L)8.00 (6.50; 12.9)11.0 (7.45; 16.3)< 0.0018.70 (6.80; 11.8)11.3 (8.05; 17.2)0.004
Local complication (%)104 (31.8) 73 (91.2) < 0.00166 (50.4) 55 (93.2) < 0.001
ICU admission (%)12 (3.67) 37 (46.2) < 0.00112 (9.16) 38 (64.4) < 0.001
ICU stays (d)0.00 (0.00; 0.00)0.00 (0.00; 10.0)< 0.0010.00 (0.00; 0.00)5.00 (0.00; 9.00)< 0.001
Hospital stays (d)10.0 (7.00; 14.0)17.5 (8.75; 25.0)< 0.0019.00 (4.00; 15.0)23.0 (15.0; 30.0)< 0.001
Mortality (%)0 (0.00) 3 (3.75) 0.0071 (0.76) 4 (6.78) 0.033
qSOFA0.00 (0.00; 0.00) 1.00 (0.00; 1.00)< 0.0010.00 (0.00; 1.00) 1.00 (0.00; 1.00) < 0.001
SIRS1.00 (0.00; 2.00)3.00 (2.00; 3.00)< 0.0011.00 (0.00; 2.00)3.00 (2.00; 3.00)< 0.001
BISAP1.00 (0.00; 1.00)2.00 (2.00; 3.00)< 0.0011.00 (0.00; 2.00)2.00 (2.00; 3.00)< 0.001
Table 2 Characteristics of non-acute respiratory distress syndrome and acute respiratory distress syndrome patients in derivation and validation cohorts
CharacteristicDerivation cohort
P valueValidation cohort
P value
non-ARDS (n = 345)
ARDS (n = 62)
non-ARDS (n = 153)
ARDS (n = 37)
Age (yr)49.0 (36.0; 64.0)42.0 (33.2; 59.5)0.06240.0 (33.0; 57.0)48.0 (41.0; 57.0)0.082
Female (%)138 (40.0) 20 (32.3) 0.31267 (43.8) 10 (27.0) 0.093
Weekend admission (%)73 (21.2) 18 (29.0) 0.22839 (25.5) 11 (29.7) 0.751
Etiology (%)0.0240.187
Biliary122 (35.4) 22 (35.5) 56 (36.6) 9 (24.3)
Hypertriglyceridemia119 (34.5) 30 (48.4) 53 (34.6) 12 (32.4)
Alcoholic28 (8.12) 6 (9.68) 8 (5.23) 5 (13.5)
Others76 (22.0) 4 (6.45) 36 (23.5) 11 (29.7)
Peritoneal irritation (%)80 (23.2) 25 (40.3) 0.00739 (25.5) 20 (54.1) 0.002
GCS < 15 (%)4 (1.16) 3 (4.84) 0.0754 (2.61) 6 (16.2) 0.004
Tem (℃)36.6 (36.4; 37.0)37.5 (36.5; 38.2)< 0.001 37.0 (36.8; 37.5)38.0 (37.8; 38.5)< 0.001
SBP (mmHg)129 (119; 140) 123 (110; 141) 0.113123 (116; 140) 119 (106; 147) 0.192
HR (bpm)82.0 (76.0; 96.0)120 (103; 134) < 0.001 90.0 (80.0; 110) 115 (100; 140) < 0.001
RR (bpm)20.0 (18.0; 20.0)23.0 (20.0; 30.0)< 0.001 20.0 (18.0; 22.0)24.0 (20.0; 29.0)< 0.001
WBC (× 109/L)11.9 (8.76; 15.3)13.9 (9.91; 19.5)0.00612.5 (9.07; 16.3)17.6 (13.6; 22.8)< 0.001
HCT (%)40.8 (37.5; 44.8)45.2 (38.3; 48.7)0.00241.3 (37.4; 45.2)43.9 (38.0; 49.4)0.094
PLT (× 109/L)218 (176; 275) 207 (167; 274) 0.26228 (192; 278) 208 (168; 261) 0.112
K (mmol/L)3.90 (3.60; 4.30)3.90 (3.50; 4.20)0.4413.90 (3.50; 4.20)3.90 (3.50; 4.40)0.429
Na (mmol/L)137 (134; 140) 137 (132; 140) 0.95137 (133; 140) 139 (132; 144) 0.038
Ca (mmol/L)2.25 (2.12; 2.34)1.88 (1.65; 2.12)< 0.001 2.16 (2.01; 2.29)1.96 (1.77; 2.22)0.002
Cr (μmol/L)67.0 (55.0; 81.0)86.5 (72.0; 134) < 0.001 62.0 (53.0; 79.0)96.0 (65.0; 230) < 0.001
BUN (mmol/L)5.03 (3.90; 6.44)7.28 (5.25; 10.3)< 0.001 4.80 (3.37; 6.48)6.97 (5.37; 14.4)< 0.001
Glu (mmol/L)8.10 (6.50; 13.1)11.0 (7.67; 16.1)< 0.001 8.80 (6.90; 13.6)11.3 (8.10; 16.8)0.032
Local complication (%)115 (33.3) 62 (100) < 0.00188 (57.5) 33 (89.2) 0.001
Ventilator (%)3 (0.87) 4 (6.45) 0.0120 (0.00) 23 (62.2) < 0.001
ICU admission (%)16 (4.64) 33 (53.2) < 0.00121 (13.7) 29 (78.4) < 0.001
ICU stays (d)0.00 (0.00; 0.00)2.50 (0.00; 11.8)< 0.001 0.00 (0.00; 0.00)7.00 (1.00; 11.0)< 0.001
Hospital stays (d)10.0 (7.00; 15.0)19.0 (11.0; 25.0)< 0.001 10.0 (4.00; 19.0)23.0 (15.0; 30.0)< 0.001
Mortality (%)1 (0.29) 2 (3.23) 0.0621 (0.65) 4 (10.8) 0.005
Table 3 Multivariable logistic regression analysis for severe acute pancreatitis and acute respiratory distress syndrome prediction in derivation cohort
VariableSAP
ARDS
β
OR (95% CI)
P value
β
OR (95% CI)
P value
Intercept-6.420.00 (0.00-0.05)< 0.001-5.460.00 (0.00-0.13)0.002
HR0.051.05 (1.04-1.07)< 0.0010.051.05 (1.03-1.07)< 0.001
RR0.081.08 (1.00-1.17)0.0470.101.10 (1.02-1.19)0.014
Ca-1.300.26 (0.09-0.73)0.011-1.780.17 (0.06-0.48)0.001
BUN0.141.15 (1.09-1.23)< 0.0010.111.12 (1.05-1.19)< 0.001
Table 4 Sensitivity, specificity, positive predictive value, negative predictive value for of the predictive models in combined cohort
SAP
ARDS
PA
SE
SP
Youden index
PPV
NPV
PA
SE
SP
Youden index
PPV
NPV
> 10%0.910.630.540.430.96> 5%0.940.480.420.260.98
> 20%0.820.830.650.590.94> 10%0.850.710.560.370.96
> 25%0.780.880.660.660.93> 18%0.780.850.630.510.95
> 40%0.710.930.640.750.91> 30%0.670.930.590.650.93
> 60%0.510.970.480.840.87> 50%0.460.960.430.710.90
> 80%0.320.990.300.880.83> 70%0.290.980.270.710.87
> 95%0.141.000.140.910.79> 85%0.121.000.120.860.85